Organon (OGN) Change in Intangibles (2021 - 2025)

Organon (OGN) posted quarterly Change in Intangibles of $69.0 million for Q3 2025, up 200.0% year-over-year from $23.0 million in Q3 2024, and up 25.45% on a QoQ basis from $55.0 million in Q1 2025.

Organon (OGN) Change in Intangibles (2021 - 2025) Analysis & Trends

Organon (OGN) has reported Change in Intangibles for 5 consecutive years, with $69.0 million the latest figure, recorded in Q3 2025.

  • In Q3 2025, Change in Intangibles rose 200.0% year-over-year to $69.0 million; the TTM figure through Mar 2026 stood at $69.0 million (down 37.27% YoY), while the FY2025 annual figure was $124.0 million, up 18.1% from the prior year.
  • Change in Intangibles came in at $69.0 million for Q3 2025 at Organon, up from $55.0 million in the prior quarter.
  • The five-year high for Change in Intangibles was $192.0 million in Q2 2021, with the low at $2.0 million in Q4 2023.
  • Average Change in Intangibles over 5 years is $51.0 million, with a median of $35.5 million recorded in 2022.
  • Across the five-year window, Change in Intangibles plunged 79.69% in 2022 and jumped 1500.0% in 2024, its largest moves.
  • Year by year, Change in Intangibles stood at $192.0 million in 2021, then plunged by 90.62% to $18.0 million in 2022, then slumped by 88.89% to $2.0 million in 2023, then surged by 1500.0% to $32.0 million in 2024, then jumped by 115.62% to $69.0 million in 2025.
  • According to Business Quant data, Change in Intangibles over the past three periods registered $69.0 million, $55.0 million, and $32.0 million for Q3 2025, Q1 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -991.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -461.00 Mn
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 69.00 Mn
Sep 30, 2025 69.00 Mn
Mar 31, 2025 55.00 Mn
Mar 31, 2025 55.00 Mn
Dec 31, 2024 32.00 Mn
Dec 31, 2024 32.00 Mn
Sep 30, 2024 23.00 Mn
Sep 30, 2024 23.00 Mn
Mar 31, 2024 50.00 Mn
Mar 31, 2024 50.00 Mn
Dec 31, 2023 2.00 Mn
Dec 31, 2023 2.00 Mn
Sep 30, 2022 18.00 Mn
Sep 30, 2022 18.00 Mn
Jun 30, 2022 39.00 Mn
Jun 30, 2022 39.00 Mn
Mar 31, 2022 30.00 Mn
Mar 31, 2022 30.00 Mn
Jun 30, 2021 192.00 Mn
Jun 30, 2021 192.00 Mn